Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) Archives

Abstract Number: 879 • ACR/ARHP Annual Meeting 2016
Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease
Sinem Nihal Esatoglu¹, Ayse Merve Celik², Didar Ucar³, Aykut Ferhat Celik⁴, Serdal Ugurlu⁵, Gulen Hatemi⁵, Melike Melikoglu⁵, Izzet Fresko⁵, Vedat Hamuryudan⁵, Huri Ozdogan⁶, Sebahattin Yurdakul⁵, Hasan Yazici⁵ and Emire Seyahi⁵, ¹Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey, ³Istanbul University, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, ⁴Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ⁶Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
Background/Purpose: Case reports and series suggest that Takayasu’s arteritis (TA) can co-exist with various inflammatory disorders. Inflammatory bowel disease [(IBD; Crohn's disease (CD) or ulcerative…
Abstract Number: 687 • ACR/ARHP Annual Meeting 2015
Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients
Amy Sargious Kehl¹, Carol Landers², Tina Wu², Dermot McGovern³ and Michael H. Weisman¹, ¹Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Cedars-Sinai Medical Center, Los Angeles, CA, ³Department of Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA
Background/Purpose: It has been observed that ankylosing spondylitis (AS) patients have a high frequency of asymptomatic chronic gut inflammation, with as many as 60% of…
Abstract Number: 2488 • ACR/ARHP Annual Meeting 2013
Elevated Serum Anti-Flagellin Antibodies Implicate Subclinical Bowel Inflammation in Ankylosing Spondylitis
Dinny Wallis¹, Arundip Asaduzzaman¹, Michael H. Weisman², Nigil Haroon¹, Ammepa Anton³, Dermot P. B. McGovern⁴, Stephan R. Targan⁵ and Robert D. Inman⁶, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²Rheumatology, Cedars-Sinai Med Ctr, Los Angeles, CA, ³Rheumatology, University Health Network, Toronto, ON, Canada, ⁴Department of Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, ⁵Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁶Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitisBackground/Purpose: Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) share genetic and clinical features. IBD…

Abstracts tagged "Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD)"

Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease

Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients

Elevated Serum Anti-Flagellin Antibodies Implicate Subclinical Bowel Inflammation in Ankylosing Spondylitis